세계의 스캐폴드 기술 시장(2023-2030년)

Global Scaffold technology Market Size, Share & Trends Analysis Report by Type (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds),by Disease Type (Orthopedics, Musculoskeletal, & Spine, Cancer, Skin & Integumentary, Dental and Others),by Application (Stem Cell Therapy, Regenerative Medicine,& Tissue Engineering, and Drug Development) and by End-User (Biotechnology & Pharmaceutical Organizations, Research Laboratories & Institutes, Hospitals & Diagnostic Centers)Forecast Period (2023-2030)

The global scaffold technology market is anticipated to grow at a considerable CAGR of 10.2% during the forecast period (2023-2030). The rising demand for organ transplant, reconstruction procedures globally and increase in R&D initiatives on the design of a 3D matrix that is based on 3D substrates is enabling the market growth. 3D culture assays such as cell to cell interactions, high throughput scanning, transfections, and cell migration assays all use scaffold technology. In addition, the tissue culture such as vascularization and organ implant regeneration applied in the treatment of damaged and diseased organs or tissues will further provide potential opportunities for the growth of the scaffold technology

Segmental Outlook

The global scaffold technology market is segmented by the type, disease type, application, and end-user. Based on the type, the market is sub-segmented into hydrogels, polymeric scaffolds, micropatterned surface microplates and nanofiber-based scaffolds. Based on disease type the market is sub-segmented into orthopedics, musculoskeletal, & spine, cancer, skin & integumentary, dental and others. Based on the application, the market is sub-segmented into stem cell therapy, regenerative medicine& tissue engineering, and drug development. Further, based on the end-user, the market is sub-segmented into biotechnology & pharmaceutical organizations, research laboratories & institutes, and hospitals & diagnostic centers. Among the type, the hydrogels sub-segment is anticipated to hold a considerable share of the market owing to technological advancements in microfabrication procedures for hydrogels are anticipated to accelerate the segment growth during the forecast period. Companies are launching new hydrogels for cell transplantation, drug depots, and a barrier against restenosis. For instance, in March, 2021 Bio-Techne Corporation announced the release of Cultrex UltiMatrix Reduced Growth Factor Basement Membrane Extract (RGF BME), an extracellular matrix hydrogel that provides significant performance and consistency benefits for culturing organoids and pluripotent stem cells.

Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering Sub-Segment is Anticipated to Hold a Considerable Share of the Global Scaffold technology Market

Among the application, the stem cell therapy, regenerative medicine & tissue engineering, and drug development sub-segment is expected to hold a considerable share of the global scaffold technology market. Scaffold technology is being utilized increasingly frequently in reconstructive surgeries, aesthetic surgeries, abdominal wall repair, periodontology, soft tissue tumor repair and colorectal treatments. According to the International Society of Aesthetic Plastic Surgery (ISAPS), a 19.3% overall increase in procedures performed by plastic surgeons in 2021 with more than 12.8 million surgical, and 17.5 million non-surgical, procedures performed globally. Transplanting blood stem cells is the most well-known and often used stem cell treatment. It may be used to treat immune system and blood system disorders, as well as to repair the blood system following treatment for certain cancers. Blood stem cells are used to treat around 26,000 patients annually in Europe.

Furthermore, researchers have become increasingly interested in the widespread use of scaffold technologies in the field of regenerative medicine. For instance, in November 2020, Wake Forest Institute for Regenerative Medicine (WFIRM) scientists, introduced a hybrid tissue structure that can be used for cartilage regeneration. It was created with the use of 3D bioprinting technology. As a result, the expanding research into tissue development can be ascribed to segment expansion.

Regional Outlook

The global scaffold technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to exhibit fastest CAGR during the forecast period. The growing presence of government organizations that conduct regenerative medicine and stem cell research is a key factor driving the regional market growth. India has a vibrant stem cell research ecosystem, with both private and government institutions contributing to the field. For instance, in 2021 financial assistance for stem cell research activities is being provided by the Indian Government. The Government of India has undertaken stem cell research through various Departments/ Institutions, including the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), and Department of Science and Technology (DST). Additionally, increasing public consciousness about the use of organ transplants and increased expenditures in healthcare infrastructure in countries such as India and China also contribute to the regional market's expansion.

North America Expected to Hold Considerable Share in the Global Scaffold technology Market

in the high incidences of cancer, increase in number of organ transplantation, and expansion of biotechnology & pharmaceutical companies is a key factor driving demand for scaffold technology. Growing R&D across the region is further contributing regional market share. For instance, in April 2023, Systemic Bio opened its new lab in Texas, US for hydrogel scaffold manufacturing and research and development activities for organ-on-a-chip technology to enhance drug discovery and development. Disease such as cancer has a major impact in the US. Cancer surgery is a common part of diagnosing and treating cancer. Surgery can show the size of the cancer and whether it has spread, which helps to figure out the cancer's stage. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the US. The most common cancers were breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, and non-Hodgkin lymphoma. Additionally due to presence of major companies including Akron Biotech, 3D Biotek LLC, Thermo Fisher Scientific Inc., Molecular Matrix Inc., Xanofi, and Corning Incorporated is propelling the region's growth.

Market Players Outlook

The major companies serving the scaffold technology market include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza Group Ltd., 3D Biotek, LLC, Molecular Matrix, Inc., PELOBIOTECH GmbH, India Medtronic Pvt Ltd., Avacta Life Sciences Ltd., AbbVie, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Evonik and BellaSeno, a developer of 3D-printed absorbable scaffolds, were working together to commercialize innovative 3D-printed scaffolds for bone regeneration. The bone scaffolds are made with Evonik's Resomer polymers and are used for large and complex bone defects. Both companies initially began collaborating in 2019 on scaffolds for chest wall and breast reconstruction.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global scaffold technology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Thermo Fisher Scientific Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Becton, Dickinson and Company
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Merck Group
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Scaffold Technology Market by Type
  • 4.1.1. Hydrogels
  • 4.1.2. Polymeric Scaffolds
  • 4.1.3. Micropatterned Surface Microplates
  • 4.1.4. Nanofiber Based Scaffolds
• 4.2. Global Scaffold Technology Market by Disease Type
  • 4.2.1. Orthopedics, Musculoskeletal, & Spine
  • 4.2.2. Cancer
  • 4.2.3. Skin & Integumentary
  • 4.2.4. Dental
  • 4.2.5. Others (Cardiology & Vascular, Neurology and Urology)
• 4.3. Global Scaffold Technology Market by Application
  • 4.3.1. Stem Cell Therapy, Regenerative Medicine, Tissue Engineering
  • 4.3.2. Drug Development
• 4.4. Global Scaffold Technology Market by End-User
  • 4.4.1. Biotechnology & Pharmaceutical Organizations
  • 4.4.2. Research Laboratories & Institutes
  • 4.4.3. Hospitals & Diagnostic Centers

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
• 5.4. Rest of Asia-Pacific
• 5.5. Rest of the World

6. Company Profiles

• 6.1. 3D Biotek, LLC
• 6.2. AbbVie Inc.
• 6.3. Akron Biotech
• 6.4. Avacta Life Sciences Ltd.
• 6.5. Avantor, Inc.
• 6.6. BICO Group
• 6.7. Corning Inc.
• 6.8. India Medtronic Pvt Ltd.
• 6.9. Lonza Group Ltd.
• 6.10. Molecular Matrix, Inc.
• 6.11. Nanofiber Solutions, LLC
• 6.12. NuVasive, Inc.
• 6.13. PELOBIOTECH GmbH
• 6.14. REPROCELL
• 6.15. Vericel Corp.